Gray/White Matter Contrast in Parkinson’s Disease

Gray/white matter contrast (GWC) decreases with aging and has been found to be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s disease (PD) patients has not been investigated. The aims of the study were to test whether GWC is sensitive to aging changes in PD patien...

詳細記述

保存先:
書誌詳細
出版年:Front Aging Neurosci
主要な著者: Uribe, Carme, Segura, Barbara, Baggio, Hugo C., Abos, Alexandra, Garcia-Diaz, Anna I., Campabadal, Anna, Marti, Maria J., Valldeoriola, Francesc, Compta, Yaroslau, Bargallo, Nuria, Junque, Carme
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2018
主題:
Neuroscience
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881246/
https://ncbi.nlm.nih.gov/pubmed/29636679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00089
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料